Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Debt-to-Equity : 0.03 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Debt-to-Equity?

Vaidyane Ayurved Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹16.8 Mil. Vaidyane Ayurved Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Vaidyane Ayurved Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹556.0 Mil. Vaidyane Ayurved Laboratories's debt to equity for the quarter that ended in Mar. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vaidyane Ayurved Laboratories's Debt-to-Equity or its related term are showing as below:

NSE:MADHAVBAUG' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.07 Max: 0.99
Current: 0.03

During the past 6 years, the highest Debt-to-Equity Ratio of Vaidyane Ayurved Laboratories was 0.99. The lowest was 0.00. And the median was 0.07.

NSE:MADHAVBAUG's Debt-to-Equity is ranked better than
88.36% of 816 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs NSE:MADHAVBAUG: 0.03

Vaidyane Ayurved Laboratories Debt-to-Equity Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Debt-to-Equity Chart

Vaidyane Ayurved Laboratories Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.73

0.10

0.03

Vaidyane Ayurved Laboratories Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial				0.03	N/A	-	0.07	0.03

Competitive Comparison of Vaidyane Ayurved Laboratories's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaidyane Ayurved Laboratories's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Vaidyane Ayurved Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vaidyane Ayurved Laboratories's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(16.782	+	0)	/	556.015
	=	0.03

Vaidyane Ayurved Laboratories's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(16.782	+	0)	/	556.015
	=	0.03

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Vaidyane Ayurved Laboratories Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaidyane Ayurved Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604

Website

https://www.madhavbaug.org

Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines